BioCentury
ARTICLE | Financial News

Valeant completes debt financing

September 27, 2010 7:00 AM UTC

Valeant Pharmaceuticals International (NYSE:VRX), Aliso Viejo, Calif. Business: Neurology, Dermatology, Autoimmune Date completed: 9/22/10 Type: Debt financing Raised: $1.5 billion Note: The financing...